Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Klin Med (Mosk) ; 68(11): 75-7, 1990 Nov.
Article in Russian | MEDLINE | ID: mdl-2283824

ABSTRACT

As early as the first 24 hours since a severe isolated locomotor trauma the patients were immunized with Proteus vaccine. Such vaccination is shown to stimulate the production of serum specific antibodies, to reduce contamination of the wound with gram-negative agents, to shorten hospital stay and healing of the wound versus subjects vaccinated with staphylococcal anatoxin and nonimmunized patients.


Subject(s)
Bacterial Vaccines/administration & dosage , Proteus/immunology , Wounds and Injuries/therapy , Bacterial Vaccines/immunology , Emergency Service, Hospital , Evaluation Studies as Topic , Female , Humans , Immunization , Male , Moscow , Staphylococcal Vaccines/administration & dosage , Wound Infection/immunology , Wound Infection/prevention & control , Wounds and Injuries/immunology
2.
Anesteziol Reanimatol ; (4): 10-4, 1990.
Article in Russian | MEDLINE | ID: mdl-2077956

ABSTRACT

Similar changes in cellular and humoral immunity indicative of the onset of toxic immune depression have been revealed in 53 patients with acute poisoning with organophosphorus insecticides and psychotropic agents. The therapy employed hemosorption (HS), blood exposure to magnetic field and ultraviolet (UV) blood irradiation. Immunocorrection was the most effective in the combination of HS with UL blood irradiation. The technique accelerated lymphocyte differentiation and stimulated metabolic activity of neutrophils. Blood exposure to magnetic field had no considerable effect on the immunity indexes.


Subject(s)
Blood/radiation effects , Hemoperfusion , Immunity , Magnetics , Organophosphate Poisoning , Psychotropic Drugs/poisoning , Ultraviolet Therapy , Humans , Immunity/radiation effects , Poisoning/immunology , Poisoning/therapy
4.
Zh Mikrobiol Epidemiol Immunobiol ; (10): 91-6, 1989 Oct.
Article in Russian | MEDLINE | ID: mdl-2514532

ABSTRACT

The influence of immune antistaphylococcal, anti-Proteus and anti-Pseudomonas aeruginosa plasma and donor leukocyte mass on some humoral and cell-mediated immunity characteristics in patients with purulent and septic diseases has been studied. The study has shown that treatment with immune plasma leads to an increase in the amount of circulating T lymphocytes and in the concentration of IgA, IgM and IgG, to the activation of phagocytosis and to an increase in the titers of the corresponding antimicrobial antibodies simultaneously with a decrease in the content of bacterial antigens in the blood serum. Treatment with donor leukocyte mass has also been found to lead to an increase in the concentration of T lymphocytes and immunoglobulins, to enhance the functional activity of phagocytizing neutrophils and to promote the normalization of the content of leukocytes in the peripheral blood. The use of these preparations as stimulating agents in the treatment of patients having purulent septic diseases and, simultaneously, low cell-mediated immunity characteristics is recommended.


Subject(s)
Blood Donors , Leukocytes/immunology , Plasma/immunology , Proteus mirabilis/immunology , Pseudomonas aeruginosa/immunology , Staphylococcus aureus/immunology , Suppuration/therapy , Antibodies, Bacterial/analysis , Antibody Formation/drug effects , Antibody Formation/immunology , Antigens, Bacterial/analysis , Humans , Immunity, Cellular/drug effects , Immunity, Cellular/immunology , Immunotherapy/methods , Suppuration/immunology , Time Factors
6.
Article in Russian | MEDLINE | ID: mdl-3087123

ABSTRACT

In experiments of the passive protection of mice the protective properties of sera obtained from humans before and after their immunization with Proteus vaccine used as a monopreparation or in combination with staphylococcal toxoid and/or pyoimmunogen were studied. When introduced in a single subcutaneous injection, Proteus vaccine prepared from soluble antigenic complexes ensured an increase in the protective properties of sera. The second injection of the vaccine essentially enhanced the protective potency of the sera of the immunized donors. The therapeutic injection of Proteus vaccine ensured the essential increase of the protective properties of the sera. This increase could be experimentally detected within at least 25-30 days from the beginning of immunization. The immunization of volunteers with Proteus vaccine in combination with pyoimmunogen and adsorbed staphylococcal toxoid ensured the maximum increase of the protective properties of their sera.


Subject(s)
Antigens, Bacterial/immunology , Bacterial Vaccines/immunology , Immune Sera/immunology , Proteus vulgaris/immunology , Vaccination , Animals , Dose-Response Relationship, Immunologic , Drug Evaluation, Preclinical , Female , Humans , Immune Sera/isolation & purification , Immunization, Passive , Male , Mice , Proteus Infections/prevention & control , Pseudomonas Vaccines , Pseudomonas aeruginosa/immunology , Solubility , Staphylococcal Toxoid/immunology , Time Factors , Vaccines, Combined
SELECTION OF CITATIONS
SEARCH DETAIL
...